5-fluorodopamine has been researched along with ascorbic acid in 1 studies
Studies (5-fluorodopamine) | Trials (5-fluorodopamine) | Recent Studies (post-2010) (5-fluorodopamine) | Studies (ascorbic acid) | Trials (ascorbic acid) | Recent Studies (post-2010) (ascorbic acid) |
---|---|---|---|---|---|
76 | 8 | 16 | 45,261 | 2,497 | 11,176 |
Protein | Taxonomy | 5-fluorodopamine (IC50) | ascorbic acid (IC50) |
---|---|---|---|
Chain A, Hyaluronidase, phage associated | Streptococcus pyogenes | 1000 | |
Urease | Canavalia ensiformis (jack bean) | 8.59 | |
Solute carrier family 23 member 1 | Homo sapiens (human) | 156 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruchelt, G; Kuci, Z; Niethammer, D; Roginsky, VA; Seitz, G; Stegmann, HB; Wolburg, H | 1 |
1 other study(ies) available for 5-fluorodopamine and ascorbic acid
Article | Year |
---|---|
6-fluorodopamine selectively destroys neuroblastoma cells expressing the noradrenaline transporter.
Topics: Ascorbic Acid; Carrier Proteins; Dopamine; Gene Expression Regulation, Neoplastic; Humans; Neuroblastoma; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Oxidopamine; Symporters; Tumor Cells, Cultured | 2000 |